Analyte Overview



Name(s): MMP-3, MMP3, CHDS6, SL-1, STMY, STMY1, STR1, Matrix Metalloproteinase-3, Stromelysin-1, 


        Human: 4500-18.52 pg/ml

Species: Human

Sample Type: Serum, Plasma

Detection: Chemiluminescent

Singleplex or Multiplex: Singleplex and Multiplex Available


Analyte Description

Matrix metalloproteinase 3 (MMP3), also known as stromelysin-1, is an enzyme that is involved with remodeling tissues. It is a member of the MMP family, a group of structural related zinc-dependent endopeptidases that are involved in breaking down different components of tissue. MMP3 is capable of degrading many components of the extracellular matrix involved in connective tissue, including collagen types II, III, IV, IX, and X, proteoglycans, fibronectin, laminin, and elastin. MMP3 is also capable of recruiting and activating other members of the MMP family. It plays roles in early development and wound healing, as well as in at artery disease and tumor formation. Following a traumatic brain or spinal cord injury, elevated levels of MMP3 can contribute to additional damage from inflammation by disrupting the blood-brain barrier/blood spinal cord barrier. Due to its dramatic remodeling capabilities which can be coopted to support tumor formation, MMP3 is implicated in a wide range of cancers.

Q-Plex™ Products featuring MMP-3

Human Multiplex Kits

As researchers and problem solvers ourselves, we understand the value of sound data. We are proud to be a part of research that can better the world. We value the relationships, partnerships, and friendships that we have built with the people who trust and use our technology. We are committed to building these relationships. You can count on us to answer the phone and take time to thoroughly address questions or concerns about any of our products. In an industry that is reputed for grandiose claims, we trust that our quality standards and our customer service set us apart from the competition. If you’re happy with our products or if you think we can do something better, we hope you will let us know.